Aaron Kesselheim, an assistant professor of medicine at Harvard Medical School and one of the study authors, said the researchers were trying to measure the impact news reports about the investigations and settlements had on the prescribing practices of doctors as well as the behavior of the drug makers.
"Certainly, the pharmaceutical companies are saying they’re changing their practices,’’ Kesselheim said. "I’m sure some of these cases have gotten attention in the industry.
"The practices,’’ he said, "are more likely changing rather than disappearing completely.’’
Tuesday, December 06, 2011
More enforcement and bigger fines may change illegal drug marketing, say Harvard researchers | NJ.com